×

Non nucleoside reverse transcriptase inhibitors

  • US 7,462,608 B2
  • Filed: 04/25/2003
  • Issued: 12/09/2008
  • Est. Priority Date: 04/26/2002
  • Status: Active Grant
First Claim
Patent Images

1. A phosphonate anolog of Efavirenz or a pharmaceutically acceptable salt, thereof.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×